1. Home
  2. ABVC vs PRPO Comparison

ABVC vs PRPO Comparison

Compare ABVC & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ABVC BioPharma Inc.

ABVC

ABVC BioPharma Inc.

HOLD

Current Price

$1.49

Market Cap

34.6M

Sector

Health Care

ML Signal

HOLD

Logo Precipio Inc.

PRPO

Precipio Inc.

HOLD

Current Price

$23.09

Market Cap

40.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABVC
PRPO
Founded
2015
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
34.6M
40.1M
IPO Year
2009
2000

Fundamental Metrics

Financial Performance
Metric
ABVC
PRPO
Price
$1.49
$23.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
115.9K
18.5K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
7.14
92.15
EPS
N/A
N/A
Revenue
$509,589.00
$24,049,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
29.77
52 Week Low
$0.88
$10.60
52 Week High
$4.02
$33.63

Technical Indicators

Market Signals
Indicator
ABVC
PRPO
Relative Strength Index (RSI) 64.59 43.02
Support Level $1.00 $21.71
Resistance Level $1.71 $25.27
Average True Range (ATR) 0.11 1.22
MACD 0.01 0.20
Stochastic Oscillator 76.87 48.61

Price Performance

Historical Comparison
ABVC
PRPO

About ABVC ABVC BioPharma Inc.

ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.

About PRPO Precipio Inc.

Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.

Share on Social Networks: